Chronomodulated Chemotherapy of Oxaliplatin Combined 5-FU and CF Plus Levamisole on Colorectal Cancer of 41 Cases
SHI Fang,LI Ling,LI Chun-lai,WU Jian-bing,FENG Long,JIANG Wei-min
DOI: https://doi.org/10.3969/j.issn.1000-2294.2009.04.019
2009-01-01
Abstract:Objective To explore the therapeutic efficacy of chronomodulated chemotherapy of oxaliplatin combined 5-FU and CF(FFP)plus levamisole(LMS)on colorectal cancer.Methods 71 patients with advanced colorectal cancer were randomly divided into two groups.Experiment group(n=41)was employed the chronomodulated chemotherapy of FFP plus LMS:① Oxaliplatin(L-OHP)was injected at 15:00-17:00 in the first day;②5-FU was infused in sine velocity with an auto-infusion pump that controlled by a microcomputer from 22:00 of the first day to 10:00 of the next day with a concentration peak at 4:00,lasted 5 days;③ Leucovorin(CF)was infused before administration of 5-FU everyday,lasted 5 days,3～4 weeks repeatedly;④All patients received LMS 50 mg p.o.t.i.d.on days 1~3,every 14 days for 12 months.Control group(n=30)was treated by injecting L-OHP 150 mg/m2,CF 200 mg/m2 and 5-FU 500 mg/m2 respectively.The therapeutic efficacy and adverse drug reaction were investigated.Results The 1,2,3 year survival rate of experiment group and control group was 96.23%,71.10%,60.83% and 80.86%,67.38%,32.44%,respectively(P<0.05).The 1,2,3 year TTP rate of experiment group was significantly lower than those of control group(58.26%,28.16%,28.16% vs 74.45%,58.22%,50.76%;P<0.05).The percentage of adverse drug reactions had no significant difference between the two groups(P>0.05).Conclusion The combination of chronomodulated chemotherapy of FFP with LMS may be more effective and may cause the lower adverse drug reactions on advanced colorectal carcinoma.